Real-world keystroke dynamics are a potentially valid biomarker for clinical disability in multiple sclerosis.

Autor: Lam, KH, Meijer, KA, Loonstra, FC, Coerver, EME, Twose, J, Redeman, E, Moraal, B, Barkhof, F, de Groot, V, Uitdehaag, BMJ, Killestein, J

Publikováno v: Multiple Sclerosis Journal; Aug2021, Vol. 27 Issue 9, p1421-1431, 11p

Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical Trial.

Autor: Coerver EME; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Fung WH; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., de Beukelaar J; Neurology, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Bouvy WH; Neurology, Diakonessenhuis, Utrecht, the Netherlands., Canta LR; Neurology, Catharina Hospital, Eindhoven, the Netherlands., Gerlach OHH; Neurology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.; School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands., Hoitsma E; Neurology, Alrijne Hospital, Leiden, the Netherlands., Hoogervorst ELJ; Neurology, St Antonius Hospital, Utrecht, the Netherlands., de Jong BA; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Kalkers NF; Neurology, OLVG, Amsterdam, the Netherlands., van Kempen ZLE; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Lövenich H; Neurology, St Jans Gasthuis, Weert, the Netherlands., van Munster CEP; Neurology, Amphia Hospital, Breda, the Netherlands., van Oosten BW; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Smolders J; MS Center ErasMS, Neurology & Immunology, Erasmus Medical Center, Rotterdam, the Netherlands., Vennegoor A; Neurology, Flevoziekenhuis, Almere, the Netherlands., Zeinstra EMPE; Neurology, Isala Hospital, Meppel, the Netherlands., Barrantes-Cepas M; MS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam University Medical Center, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Kooij G; MS Center Amsterdam, Molecular Cell Biology and Immunology, Amsterdam Neuroscience, Amsterdam University Medical Center, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Schoonheim MM; MS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam University Medical Center, location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Moraal B; MS Center Amsterdam, Radiology & Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Barkhof F; MS Center Amsterdam, Radiology & Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, United Kingdom., Uitdehaag BMJ; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Mostert J; Neurology, Rijnstate Hospital, Arnhem, the Netherlands., Killestein J; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands., Strijbis EMM; Multiple Sclerosis Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical Center location VUmc, Amsterdam, the Netherlands.

Publikováno v: JAMA neurology [JAMA Neurol] 2024 Dec 09. Date of Electronic Publication: 2024 Dec 09.

Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis.

Autor: Coerver EME; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands. Electronic address: e.coerver@amsterdamumc.nl., Bourass A; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Wessels MHJ; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., van Kempen ZLE; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Jasperse MMS; MS Center Amsterdam, Radiology & Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Tonino BAR; Rijnstate Hospital, Department of Radiology, Arnhem, The Netherlands., Barkhof F; MS Center Amsterdam, Radiology & Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, United Kingdom., Mostert J; Rijnstate Hospital, Department of Neurology, Arnhem, The Netherlands., Uitdehaag BMJ; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Killestein J; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands., Strijbis EMM; MS Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Jun; Vol. 74, pp. 104706. Date of Electronic Publication: 2023 Apr 03.

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis.

Autor: Coerver EME; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Strijbis EMM; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Petzold LF; Department of Neurology, Maidstone and Tunbridge Wells NHS Trust, Kent, United Kingdom., Van Kempen ZLE; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Jasperse B; Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Barkhof F; Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.; Centre for Medical Image Computing, Queen Square Institute of Neurology, University College London, London, United Kingdom., Oudejans CBM; Molecular Biology Laboratory, Department of Clinical Chemistry, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Uitdehaag BMJ; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Teunissen CE; Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Killestein J; Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Publikováno v: Frontiers in neurology [Front Neurol] 2022 Aug 17; Vol. 13, pp. 907245. Date of Electronic Publication: 2022 Aug 17 (Print Publication: 2022).

Natalizumab discontinuation in a Dutch real-world cohort.

Autor: Coerver EME; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands. Electronic address: e.coerver@amsterdamumc.nl., Wessels MHJ; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., van Lierop ZYG; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., van Kempen ZLE; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Killestein J; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands., Strijbis EMM; Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2021 Jul; Vol. 52, pp. 102974. Date of Electronic Publication: 2021 Apr 24.